` Comparison: VIRP vs ROG - Alpha Spread

VIRP
vs
ROG

Over the past 12 months, VIRP has outperformed ROG, delivering a return of +5% compared to the ROG's +4% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
VIRP
ROG
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

VIRP Intrinsic Value
HIDDEN
Show
ROG Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Virbac SA
PAR:VIRP
328.5 EUR
Roche Holding AG
SIX:ROG
322.3 CHF
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
VIRP, ROG

VIRP
ROG
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Virbac SA
Revenue
Roche Holding AG
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
VIRP, ROG

VIRP
ROG
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Virbac SA
PAR:VIRP
Roche Holding AG
SIX:ROG
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

VIRP
53.8%
ROG
73.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Virbac SA
Roche Holding AG

Operating Margin

VIRP
31.1%
ROG
35%
LTM 3Y Avg 5Y Avg 10Y Avg
Virbac SA
Roche Holding AG

Net Margin

VIRP
26.7%
ROG
20.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Virbac SA
Roche Holding AG

FCF Margin

VIRP
5.1%
ROG
17.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Virbac SA
Roche Holding AG

ROE

VIRP
45.9%
ROG
39.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Virbac SA
Roche Holding AG

ROA

VIRP
26.2%
ROG
12.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Virbac SA
Roche Holding AG

ROIC

VIRP
32.6%
ROG
19.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Virbac SA
Roche Holding AG

ROCE

VIRP
41.6%
ROG
29.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Virbac SA
Roche Holding AG

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
VIRP, ROG

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VIRP, ROG

Performance Gap Between VIRP and ROG
HIDDEN
Show

Performance By Year
VIRP, ROG

Loading
VIRP
ROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare VIRP to other stocks
LLY
Eli Lilly and Co
More expensive
vs VIRP
JNJ
Johnson & Johnson
More expensive
vs VIRP
AZN
AstraZeneca PLC
More expensive
vs VIRP
NOVN
Novartis AG
More expensive
vs VIRP
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett